Paula Lorgelly is a Professor of Health Economics in the Department of Applied Health Research at University College London. Paula leads the Health Economics theme in UCL's Populations and Lifelong Health Research Domain and is the leader of the Health Economics and Data Theme in the NIHR North Thames ARC.
Paula has nearly 20 years’ experience working in academia in the United Kingdom, Australia and New Zealand (including a visiting position in Germany) and the independent sector in the United Kingdom.
Whilst in Australia she was a member of the Economics Sub-Committee of the Pharmaceutical Benefits Advisory Committee (PBAC), and in this capacity provided advice on the effectiveness and cost-effectiveness of treatments seeking reimbursement on the Pharmaceutical Benefits Scheme.
Paula has worked across the health and medical spectrum and much of her clinical research has focused on oncology, particularly genomics and precision medicine. Her current research focuses on outcomes: comparing different HRQoL instruments, eliciting patient preferences and the use of outcomes in outcome-based payment or incentive schemes.
Paula is the national organiser of the UK Health Economists’ Study Group, an elected position. She is a member of the EuroQol Group, and on the Editorial Boards of the Journal of Cancer Policy and The Patient.